close
close

Mondor Festival

News with a Local Lens

Kerry Group acquires lactose testing technology
minsta

Kerry Group acquires lactose testing technology

This audio is automatically generated. Please let us know if you have any comments.

Diving brief:

  • Kerry Group acquired DirectSens LactoSens Technologya lactose detection test for dairy products. Financial details were not disclosed.
  • LactoSens technology, which helps verify low-lactose and lactose-free claims, is widely used in food and beverage manufacturing. It allows producers to meet regulatory requirements while running their processes more efficiently.
  • The directors of the company based in Ireland The nutrition and ingredients supplier said the acquisition enhance its ability to provide more robust solutions for lactose-free dairy products.

Dive overview:

DirectSensLactoSens The technology touts its ability to deliver accurate results without being disrupted by other factors, such as coffee, chocolate or sugar. He also notes that it works faster than other tests on the market, thus preserving the quality of the dairy products tested such as milk.

Lactose is a sugar found in milk and other dairy products. Many consumers have found that it adds texture and retains water in many food products. Some consumers found sugar uncomfortable to digest, giving rise towithout air products as well as technologies that can eliminate the ingredient while preserving the integrity of a product.

“We are delighted to introduce LactoSens into the Kerry Group portfolio to add a new element to our offering, as we fully integrate LactoSens into our wider solutions for the food and beverage industry,” said Ronan Moloney, Vice President -president of enzymes at Kerry. a declaration.

As a contract manufacturer, DirectSens will continue to oversee the production of LactoSens. The company will also continue to create new products. These include OatSens, which measures the sugar content of oat drinks; LactaZyme, a lactate detector; and XPressGT, which supports early detection of diabetes and gestational diabetes.

The LactoSens purchase is Kerry’s most recent acquisition in expanding its technology portfolio. Last year she acquired the global lactase enzyme activity of Chr. Hansen and Novozymes.